1. Home
  2. LVS vs DGX Comparison

LVS vs DGX Comparison

Compare LVS & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Las Vegas Sands Corp.

LVS

Las Vegas Sands Corp.

HOLD

Current Price

$38.74

Market Cap

31.2B

ML Signal

HOLD

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$237.20

Market Cap

26.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LVS
DGX
Founded
1988
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.2B
26.2B
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
LVS
DGX
Price
$38.74
$237.20
Analyst Decision
Buy
Buy
Analyst Count
14
13
Target Price
$69.21
★ $214.38
AVG Volume (30 Days)
★ 4.8M
892.5K
Earning Date
04-22-2026
04-21-2026
Dividend Yield
★ 2.23%
1.82%
EPS Growth
★ 19.90
13.78
EPS
1.38
★ 5.08
Revenue
★ $13,017,000,000.00
$11,035,000,000.00
Revenue This Year
$7.24
$7.53
Revenue Next Year
$4.49
$3.77
P/E Ratio
★ $28.24
$46.49
Revenue Growth
★ 15.22
11.78
52 Week Low
$38.06
$171.18
52 Week High
$70.45
$248.84

Technical Indicators

Market Signals
Indicator
LVS
DGX
Relative Strength Index (RSI) 24.38 48.15
Support Level N/A $230.43
Resistance Level $55.13 $240.13
Average True Range (ATR) 0.97 5.39
MACD -0.24 -1.07
Stochastic Oscillator 10.84 44.49

Price Performance

Historical Comparison
LVS
DGX

About LVS Las Vegas Sands Corp.

Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and Vici in 2022. After the sale of its Vegas assets, Sands generates all its EBITDA from Asia, with its casino operations generating the majority of sales.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: